About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Spain's Ferrer International Partners With Dr.Reddy's Lab to Launch Somazia in India

by Julia Samuel on May 18, 2015 at 4:37 PM
Font : A-A+

Spain's Ferrer International Partners With Dr.Reddy's Lab to Launch Somazia in India

Dr.Reddy's Laboratories have announced the launch of Somazina, the innovator brand of Citicolin in India. Dr. Reddy's has partnered with Ferrer International S.A., Spain, the global innovator of Citicoline, to make Somazina available in India.

The drug is vital in the management of stroke and has been used for the treatment of post-stroke patients around the world.

Advertisement

Somazina is indicated to improve cognitive function in patients who have suffered from stroke or cerebral infarction, or who have undergone a brain surgery or have suffered from head injuries.

The brand, Citicoline is widely used as a neuro-protectant to help accelerate the recovery from stroke. It is used in both ischemic and haemorrhagic strokes, and provides a compelling option to physicians treating stroke patients.
Advertisement

"Citicoline is safe to use and may have a beneficial effect in stroke patients. Citicoline is the only drug, that in a number of different clinical stroke trials, has had some neuroprotective effect." shared Dr. Atul Prasad, Director & Sr. Consultant, BLK Super specialty hospital, Delhi.

Cerebral Stroke is the third leading cause of deaths in India, as per the Global Burden of Disease Study 2013. "Stroke is a major cause of disability and death in India. There is a pressing need for novel neuroprotective agents which can salvage brain tissue and optimize the functional outcome," said Subhash Kaul, renowned senior neurologist from NIMS, Hyderabad.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
How to Deal with a Stroke
Stroke is a brain attack, which occurs when the blood supply to the brain is interrupted. It ......
Stroke
Stroke can cause permanent disability and it is important to recognize its early warning signs to .....
Stroke Survivors Need Emotional Support
About 152,000 individuals in England are affected by stroke annually. The repercussions of stroke .....
Apixaban : New Stroke Drug Available on NHS
A new drug apixaben is now available that can treat stroke resulting from atrial fibrillation more ....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use